Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Synthetic Gene Circuits Global Market Report 2026-2030: Trends and Forecast | Capitalize on 18.1% CAGR and AI-Driven Design with Thermo Fisher, GenScript, and Ginkgo Bioworks

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a key company in the synthetic gene circuits market report, indicating its involvement in this growing sector. The article does not provide specific sentiment towards the company's performance.

Synthetic Gene Circuits Global Market Report 2026-2030: Trends and Forecast | Capitalize on 18.1% CAGR and AI-Driven Design with Thermo Fisher, GenScript, and Ginkgo Bioworks Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Synthetic Gene Circuits Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global synthetic gene circuits market is experiencing rapid expansion as advances in biotechnology, precision medicine, and programmable cellular therapies accelerate commercial and research applications. The market is expected to grow from $2.02 billion in 2025 to $2.38 billion in 2026, representing a compound annual growth rate (CAGR) of 17.9%.

Historical market growth has been supported by advances in molecular biology techniques, rising biotechnology research investment, increased use of synthetic gene circuits in academic studies, growing demand for targeted therapeutics, and the expansion of industrial biotechnology. These factors have strengthened the development of programmable biological systems that can regulate gene expression and cellular behavior with increasing precision.

Looking ahead, the synthetic gene circuits market is forecast to reach $4.64 billion by 2030, expanding at a CAGR of 18.1%. Growth during the forecast period is expected to be driven by the integration of artificial intelligence into gene circuit design, broader synthetic biology applications in healthcare, demand for programmable cell therapies, advances in environmental biosensing, and the adoption of automated high-throughput screening technologies.

Key synthetic gene circuits market trends include the development of programmable gene expression systems, synthetic biological oscillators, advanced genetic toggle switches, cell-based biosensors, and metabolic pathway engineering. These technologies are creating new opportunities across healthcare, biotechnology research, drug development, industrial production, and environmental monitoring.

The rising demand for precision medicine is a major growth driver for the synthetic gene circuits industry. The increasing prevalence of cancer and rare genetic disorders is creating greater demand for targeted, mutation-specific treatments. Synthetic gene circuits support this shift by enabling programmable control of gene expression and cellular responses, helping researchers develop highly specific therapeutic interventions tailored to individual patient needs.

Evidence of this trend can be seen in the growing number of personalized treatments receiving regulatory approval. In February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six approvals in 2022. This increase highlights the expanding role of precision therapeutics and supports continued demand for advanced gene circuit technologies.

Innovation in modular synthetic gene circuits is also reshaping the competitive landscape. Researchers and technology developers are pursuing systems that provide precise, scalable, and programmable control of cellular functions for therapeutic and scientific applications. In October 2025, engineers at the Massachusetts Institute of Technology developed DIAL, a modular synthetic gene circuit designed to control transgene expression in cells. The system uses editable spacers between transcription factor binding sites and promoters, allowing gene expression levels to be adjusted across a wide dynamic range. Potential applications include gene therapy, cell reprogramming, and other advanced biomedical uses.

Increasing research and development investment is further supporting synthetic gene circuits market growth. Public agencies, academic institutions, and private biotechnology organizations are directing more funding toward precision therapeutics, synthetic biology, and next-generation biomedical solutions. This investment is helping researchers design, refine, validate, and commercialize increasingly sophisticated programmable biological components.

According to the National Center for Science and Engineering Statistics, U.S. research and development expenditures increased from $892 billion in 2022 to $940 billion in 2023, a rise of $48 billion. Continued investment at this scale is expected to accelerate innovation, improve commercialization pathways, and strengthen the adoption of synthetic gene circuits across healthcare and industrial biotechnology.

North America was the largest region in the synthetic gene circuits market in 2025, supported by its established biotechnology sector, substantial research funding, and strong precision medicine ecosystem. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.

Markets Covered:

1) By Product Type: Toggle Switches; Oscillators; Logic Gates; Other Product Types

2) By Application: Healthcare and Therapeutics; Industrial Biotechnology; Research and Development; Agriculture; Other Applications

3) By End User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Other End Users

Subsegments:

1) By Toggle Switches: Single Input Toggle Switches; Double Input Toggle Switches; Inducible Toggle Switches; Bistable Genetic Toggle Switches; Reversible Genetic Toggle Switches

2) By Oscillators: Repressilator Circuits; Feedback Loop Oscillators; Inducible Genetic Oscillators; Synthetic Biological Clocks; Multi Component Oscillators

3) By Logic Gates: And Logic Gates; Or Logic Gates; Not Logic Gates; Nand Logic Gates; Nor Logic Gates; Exclusive Or Logic Gates

4) By Other Product Types: Signal Amplifier Circuits; Memory Storage Circuits; Pattern Formation Circuits; Sensor Responsive Circuits; Programmable Gene Expression Circuits

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Companies Featured

The companies featured in this Synthetic Gene Circuits market report include:

For more information about this report visit https://www.researchandmarkets.com/r/bcwz5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.